Clik here to view.
WB starts Tandem Diabetes Care at outperform
William Blair has initiated coverage of Tandem Diabetes Care (NASDAQ:TNDM) with an “outperform” rating and “aggressive growth” profile. The stock closed at $13.37 on Tuesday. Tandem Diabetes makes and...
View ArticleClik here to view.
Tandem takes consumer device approach to insulin pumps
Tandem Diabetes (NASDAQ:TNDM), which now markets the popular t:slim Insulin Pump for people with Type 1 diabetes and has two new pumps awaiting FDA clearance, has taken a unique consumer-focused...
View ArticleClik here to view.
BioLight’s Eye-D to be featured at Boston conference
BioLight Life Sciences Investments’ (OTCQX:BLGTY; TASE:BOLT) Eye-D platform insert will be presented at the 5th Annual Partnership Opportunities in Drug Delivery conference in Boston on Oct. 5. The...
View ArticleClik here to view.
BTIG starts Insulet, Intersect at neutral
BTIG Research initiated research of Insulet (NASDAQ:PODD) and Intersect ENT (NASDAQ:XENT) with “neutral” ratings. Shares of Insulet closed at $32.21 and shares of Intersect at $13.51 on Tuesday....
View Article
